Action CS Diagnostics (QB) - CSDX

CS Diagnostics Corporation (QB) (CSDX) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,0514

( -20,92% )

Prix Achat

0,051

Prix Vente

0,0679

Volume échangé

577

0,0514 Fourchette du Jour 0,0649

0,036 Plage de 52 semaines 0,40

Cap du marché

12,85M

Clôture Veille

0,065

Ouverture

0,0649

Dernière Transaction

0.0649

Dernière heure de transaction

Volume financier

US$ 31

VWAP

0,0541

Volume moyen (3 m)

US$ 89 915

Actions en circulation

249 992 200

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

344,72

Bénéfice par action (BPA)

Chiffre d'affairess (LTM)

204k

Bénéfice net (LTM)

71,22k

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation ther... CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming. Show more

Secteur

Healthcare

Industrie

Medical Equipment & Supplies

Site Web

csdcorp.us

Siège social

Cheyenne, United States

Fondé

1996

CS Diagnostics Corporation (QB) est coté dans le secteur Healthcare de la OTC Markets avec le ticker CSDX. Le dernier cours de clôture d'CS Diagnostics (QB) était de US$0,07. Au cours de la dernière année, les actions de CS Diagnostics (QB) ont été négociées dans une fourchette de prix de US$ 0,036 à US$ 0,40.

CS Diagnostics (QB) compte actuellement 249 992 200 actions en circulation. La capitalisation boursière d'CS Diagnostics (QB) est de US$12,85 million. CS Diagnostics (QB) a un ratio cours/bénéfice (ratio PE) de 344.72.

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the...

Form 3 - Initial statement of beneficial ownership of securities

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products

CHEYENNE, Wyo., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX), a medical technology...

CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP

CHEYENNE, Wyo., Jan. 21, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) today detailed its...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.01965	-27.6565798733	0.07105	0.1	0.05078	249642	0.07127639	CS
4	-0.0536	-51.0476190476	0.105	0.15	0.05078	142000	0.07687675	CS
12	-0.1026	-66.6233766234	0.154	0.2399	0.05078	110429	0.10684524	CS
26	-0.1186	-69.7647058824	0.17	0.398	0.05078	72598	0.14018775	CS
52	-0.04072	-44.2032132002	0.09212	0.4	0.036	55455	0.12705628	CS
156	-0.724944	-93.3792236431	0.776344	3.5	0.036	53726	0.15407678	CS
260	-0.724944	-93.3792236431	0.776344	3.5	0.036	53726	0.15407678	CS

CSDX - Frequently Asked Questions (FAQ)

What is the current CS Diagnostics Corporation (QB) share price?

The current share price of CS Diagnostics Corporation (QB) is US$ 0,0514

How many CS Diagnostics Corporation (QB) shares are in issue?

CS Diagnostics Corporation (QB) has 249 992 200 shares in issue

What is the market cap of CS Diagnostics Corporation (QB)?

The market capitalisation of CS Diagnostics Corporation (QB) is USD 12,85M

What is the 1 year trading range for CS Diagnostics Corporation (QB) share price?

CS Diagnostics Corporation (QB) has traded in the range of US$ 0,036 to US$ 0,40 during the past year

What is the PE ratio of CS Diagnostics Corporation (QB)?

The price to earnings ratio of CS Diagnostics Corporation (QB) is 344,72

What is the cash to sales ratio of CS Diagnostics Corporation (QB)?

The cash to sales ratio of CS Diagnostics Corporation (QB) is 119,97

What is the registered address of CS Diagnostics Corporation (QB)?

The registered address for CS Diagnostics Corporation (QB) is 1603 Capitol Avenue, Cheyenne, Wyoming, 82001

What is the CS Diagnostics Corporation (QB) website address?

The website address for CS Diagnostics Corporation (QB) is csdcorp.us/

Which industry sector does CS Diagnostics Corporation (QB) operate in?

CS Diagnostics Corporation (QB) operates in the Medical Equipment & Supplies sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CS Diagnostics Corporation (QB) (CSDX)

CS Diagnostics Corporation (QB) (CSDX) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de CS Diagnostics Corporation (QB)

CSDX Dernières nouvelles

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products

CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products

CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

CSDX - Frequently Asked Questions (FAQ)

CSDX Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités